Search Results 161-170 of 17553 for colitis
Inflammatory bowel disease, particularly microscopic (lymphocytic and collagenous) colitis · Pouchitis · Clostridium difficile infection · Sclerosing mesenteritis ...
A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis Patients Who Are Naive to TNF Inhibitors.
... colitis (UC). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns ...
Inflammatory bowel disease — Crohn's disease and ulcerative colitis · Diverticulitis and diverticular disease; Anal problems such as hemorrhoids, fistula and ...
... colitis or Crohn's disease. This new vaccine has been found to be more effective than the existing vaccine Engerix in people without ulcerative colitis or ...
Mayo Clinic researcher Edward V. Loftus Jr., M.D., is a gastroenterologist studying ulcerative colitis and Crohn's disease.
A Study of the Effectiveness of Methotrexate as Initial Treatment and Maintenance of a Steroid Free Remission in Ulcerative Colitis · More about research at Mayo ...
... colitis and Crohn's disease, as well as in the management of complex cases of microscopic colitis. In addition, she has expertise in the evaluation and ...
The purpose of this study is to assess the effectiveness and safety of SER-287 in adults with active mild-to-moderate ulcerative colitis. Participation ...
The purpose of this study is to evaluate the safety, tolerability and microbiome dynamics of SER-287 in subjects with mild-to-moderate ulcerative colitis.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.